Vaccitech’s prostate cancer therapeutic has shown high level ... to date – the T-cell responses to the company’s viral vector platform are among the highest that have been achieved in ...

Choose from Colon Cancer Vector stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection Essentials ...

Outranked only by skin cancer, prostate cancer is the second most common cancer in men in the U.S. Although one in every ...

The FDA has approved Gozellix (kit for the preparation of gallium Ga 68 gozetotide injection), a radioactive diagnostic agent for prostate cancer detection.

Before a prostate biopsy is performed, various preliminary screening procedures are typically conducted. These include a ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

First patient dosed in phase 1b/2a trial for castration-resistant metastatic prostate cancer, evaluating pocenbrodib alone and with other drug combinations. The FDA has approved the use of Gozellix, a ...

The radioligand agent is now approved for use before chemotherapy in patients who have been treated with an androgen receptor ...

Scientists have found a way to 'intercept' pancreatic cancer. By inhibiting the cancer gene FGFR2, they were able to slow tumor formation. By targeting the FGFR2 and EGFR proteins, they were able to ...

Breast, pancreatic, and prostate cancers have a disproportionately higher rate of aggressive tumor grade in the target ...

BPH is more common as men age. According to the Prostate Cancer Foundation, about 20% of men in their 50s have an enlarged prostate, 60% of men in their 60s, and 70% of men by age 70. Let’s ...